ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,003Medicare Part D Prescriptions Filled, Including Refills

Rank: 147 out of 761

$452K Total Retail Price of All Prescriptions

Rank: 165 out of 761

518 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 518 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 518 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 7,923 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 483 448 1 3
LISINOPRIL 305 274 2 1
FUROSEMIDE 292 272 3 7
HYDROCODONE-ACETAMINOPHEN 277 227 S3 4 5
SIMVASTATIN 260 229 5 2
AMLODIPINE BESYLATE 245 240 6 6
OMEPRAZOLE 244 213 7 4
WARFARIN SODIUM 230 223 8 9
ATENOLOL 200 173 9 8
LOVASTATIN 180 160 10 17
HYDROCHLOROTHIAZIDE 168 160 11 11
ALENDRONATE SODIUM 152 141 12 21
LOSARTAN POTASSIUM 145 145 13 13
CITALOPRAM HBR 137 129 14 19
ZOLPIDEM TARTRATE 136 104 15 22
METOPROLOL TARTRATE 131 120 16 14
ATORVASTATIN CALCIUM 129 121 17 12
METFORMIN HCL 128 103 18 10
GABAPENTIN 125 91 19 15
FLUTICASONE PROPIONATE 122 104 20 29
OXYCODONE HCL 114 72 S2 21 24
TRAZODONE HCL 103 97 22 23
NAMENDA 99 99 23 59
METOPROLOL SUCCINATE 93 84 24 16
TRIAMTERENE-HCTZ 83 76 25 42
POTASSIUM CHLORIDE 83 81 25 18
SERTRALINE HCL 81 76 27 25
SULFAMETHOXAZOLE-TRIMETHOPRIM 81 69 27 117
TRAMADOL HCL 76 74 29 34
ADVAIR DISKUS 74 56 30 37
MORPHINE SULFATE ER 72 16 S2 31 38
DIVALPROEX SODIUM 70 70 32 97
VERAPAMIL ER 68 63 33 109
DONEPEZIL HCL 66 66 34 33
PANTOPRAZOLE SODIUM 63 63 35 40
LIDODERM 58 55 36 163
PROAIR HFA 55 42 37 32
ACETAMINOPHEN-CODEINE 51 49 S3 38 118
CARVEDILOL 51 42 38 26
VENLAFAXINE HCL ER 50 26 40 76
FLUOXETINE HCL 50 34 40 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.